Expressão de PRSS11, MTSS1, CLPTM1, SMYD2, NOTCH1 e RPL37A em fatias de carcinoma de mama de cadelas e correlação com resposta à doxorrubicina in vitro

@inproceedings{Sobral2006ExpressoDP,
  title={Express{\~a}o de PRSS11, MTSS1, CLPTM1, SMYD2, NOTCH1 e RPL37A em fatias de carcinoma de mama de cadelas e correlaç{\~a}o com resposta {\`a} doxorrubicina in vitro},
  author={Renata Afonso Sobral},
  year={2006}
}
View via Publisher
teses.usp.br

References

SHOWING 1-10 OF 78 REFERENCES
PREVALÊNCIA DE NEOPLASIAS E MODALIDADES DE TRATAMENTOS EM CÃES, ATENDIDOS NO HOSPITAL VETERINÁRIO DA UNIVERSIDADE FEDERAL DO PARANÁ
TLDR
The increasing number of cancer cases found during these period of time at the University of Parana Veterinary Hospital has shown the need of veterinarians and of Veterinary Medicine students to intensively dedicate themselves to the field of oncology, a fact that has become imperative in the professional practice as well as in this important field of medical research.
Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.
TLDR
A critical review and meta-analysis of studies examining MDR1/gp170 expression in breast cancer to estimate the likely prevalence and clinical relevance of this expression and found data are consistent with a contributory role in the multidrug resistance in some breast tumors.
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
TLDR
Survival analyses on a subcohort of patients with locally advanced breast cancer uniformly treated in a prospective study showed significantly different outcomes for the patients belonging to the various groups, including a poor prognosis for the basal-like subtype and a significant difference in outcome for the two estrogen receptor-positive groups.
High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival.
TLDR
The data identify novel prognostic markers for breast cancer, suggest a mechanism whereby Notch is activated in aggressive breast tumors, and suggest a signaling pathway activated in poor prognosis breast cancer which can be therapeutically targeted.
A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis.
TLDR
Transfection assay showed that the CDDP-sensitive strain 2008 with CRR 9 was more sensitive to CDDP, indicating that CRR9 was not associated with theCDDP-resistance, but the CD DP-induced apoptosis.
Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology.
TLDR
The reduction of MIM-A gene expression in prostate cancer and other cancers may contribute to tumor growth and development, as well as metastasis, and implicate a role of M IM-A in the regulation of cellular proliferation.
TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.
TLDR
TP53 mutations, as well as p53 protein overexpression, to be associated with response to chemotherapy, whereas clinical response to FEC was found to be dependent on normal p53, the cytotoxicity of paclitaxel was related to defective p53.
Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines.
c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors.
TLDR
The results suggest that some of the biological and morphological characteristics of the tumor are associated in canine mammary gland tumors, as also reported for human breast cancer, and shows that the immunoexpression of c-erbB-2 can be a factor in mammary carcinogenesis.
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
...
...